Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals

Table 2

Laboratory findings of white cell subpopulations in patients with diabetes or not infected with COVID-19.

Variables		NDM ()			T2D ()			value
(×10^9/L)	Normal range	Median	Increased no. (%)	Decreased no. (%)	Median	Increased no. (%)	Decreased no. (%)
WBC	3.5-9.5	4.74	0 (0.0%)	5 (15.2%)	6.05	6 (16.2%)	2 (5.4%)
NEU	1.8-6.3	2.50	1 (3.0%)	2 (6.1%)	4. 10	10 (27.0%)	0 (0.0%)
LYM	1.1-3.2	1.43	0 (0.0%)	17 (39.5%)	0.98	3 (8.1%)	18 (48.7%)	0.097
ESO	0.02-0.52	0.08	0 (0.0%)	8 (24.3%)	0.02	0 (0.0%)	16 (43.2%)
BAS	0-0.06	0.02	2 (6.1%)	0 (0.0%)	0.03	1 (2.7%)	0 (0.0%)	0.960
MON	0.1-0.6	0.45	7 (21.2%)	0 (0.0%)	0.52	11 (29.7%)	0 (0.0%)	0.264

¹WBC: white blood cell count; NEU: neutrophil count; LYM: lymphocyte count; ESO: eosinophil count; BAS: basophil count; MON: monocyte count. ²Note that the values were calculated by comparisons of absolute values (medians or means) in this table.